The French drugmaker said it intended to further investigate an advanced pre-clinical vaccine candidate previously developed against the SARS virus in the early 2000s, which it believes could protect against the latest coronavirus.
At least a dozen drugmakers are working on vaccines or antivirals and other treatments to help those infected with the fast-spreading contagion.
Johnson & Johnson said last week it was collaborating with BARDA to speed up development of a coronavirus vaccine.